QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW
13,020
+270 (2.12%)
At close: Apr 23, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 10.70B | 9.30B | 1.01B |
Biotechnology (Startups) Growth | 14.99% | 819.58% | - |
| 10.70B | 9.30B | 1.01B |
| 14.99% | 819.58% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 10.18B | 8.46B | 1.01B |
| 20.41% | 735.95% | - |
| 514.05M | 846.11M | - |
| -39.25% | - | - |
| 10.70B | 9.30B | 1.01B |
| 14.99% | 819.58% | - |
Source: S&P Global Market Intelligence.